Evo uses Iris high-definition, AI-enhanced imaging to help deliver high-quality images that enable clinicians to identify at-risk organs and tumors when delivering radiation therapy. The platform allows physicians to see target areas and critical structures for every fraction with greater clarity.

Already available in Europe, Evo continues to gain traction, Elekta said in a news release. The company believes it sets “new benchmarks” in radiation therapy as more clinics adopt the technology.

Unlike conventional cone-beam computed tomography (CT) imaging, Evo uses AI to reduce scatter and enhance image construction. This, Elekta says, leads to clearer images and helps clinicians see structures more accurately. Altogether, it supports better decision-making. Iris features AI-enhanced image quality to allow for easy upgrading on existing Elekta linacs as well.